Arkolith/Insider Trading/NRBO/Form 4

Price Ben Gil

CEO and PresidentNeuroBo Pharmaceuticals, Inc. (NRBO) · full profile →Form 4 · filed Nov 4, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 3, 2021Grant(A)617K—$0617K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001596771-21-000068) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML